| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 09/15/2005 | US20050203100 Administering acridin-9-yl-[4-(4-methylpiperazin-1-yl)-phenyl]amine (JP-1302); cognition activators, drug abuse, alcoholism, cigarette smoking cessation, schizophrenia, Tourette*s syndrome, epilepsy, psychosis; sexual, psychological, obsessive-compulsive, or nervous system disorders; psychiatry |
| 09/15/2005 | US20050203096 Compounds to treat Alzheimer's disease |
| 09/15/2005 | US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/15/2005 | US20050203030 Novel effectors of dipeptidyl peptidase IV |
| 09/15/2005 | US20050202412 Potentiators of serotonin reuptake inhibitors; cyclohexane carboxylic acid-((1r)-1-cyclohexylmethyl-2-(4-(2-methoxy phenyl)-piperazin-1-yl)ethyl)amide derivatives; for treatment of schizophrenia, paranoia and mano-depressive illness |
| 09/15/2005 | CA2557322A1 Inhibitors of hepatitis c virus ns3 protease |
| 09/15/2005 | CA2557262A1 Medicament for preventing and/or treating ischemic cardiovascular disease |
| 09/15/2005 | CA2552907A1 Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds |
| 09/14/2005 | EP1572678A2 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 09/14/2005 | EP1572649A2 3-amino-piperidine derivatives and processes for their preparation |
| 09/14/2005 | EP1572632A1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists |
| 09/14/2005 | EP1572630A1 Antibacterial agents |
| 09/14/2005 | EP1572629A1 COMPOUNDS WHICH MODULATE PPARϝ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS |
| 09/14/2005 | EP1409440A4 A method to inhibit ethylene responses in plants |
| 09/14/2005 | EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 09/14/2005 | EP1250317B1 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
| 09/14/2005 | EP1091737B1 Use of 1-(3,3-diphenylpropionyl)-4-benzhydril piperazine in the treatment of pain |
| 09/14/2005 | CN1668604A Novel anthracene derivatives and the use thereof as a medicament |
| 09/14/2005 | CN1668303A Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 09/14/2005 | CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 09/14/2005 | CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/13/2005 | US6943269 Contrast media for angiography |
| 09/13/2005 | US6943253 6-phenylpyrrolopyrimidinedione derivatives |
| 09/13/2005 | US6943196 NF-κB inhibitor comprising phenylmethyl benzoquinone as the active ingredient |
| 09/13/2005 | US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease |
| 09/13/2005 | US6943184 For therapy of Alzheimer's disease, Parkinson's disease, Pick's disease, Korsakoff s disease cerebral ageing, of mood disorders, of pain and of tobacco withdrawal |
| 09/13/2005 | US6943168 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 09/09/2005 | WO2005082893A2 Histamine h3 receptor antagonists, preparation and therapeutic uses |
| 09/09/2005 | WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof |
| 09/09/2005 | WO2005048810A3 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
| 09/09/2005 | CA2825161A1 Catalytic radiofluorination |
| 09/08/2005 | US20050197392 O-desmethylvenlafaxine and methods of preparing and using the same |
| 09/07/2005 | EP1571154A1 Beta-aminoacid-derivatives as factor Xa inhibitors |
| 09/07/2005 | EP1571140A1 C-substituted cyclohexylmethylamine derivatives |
| 09/07/2005 | EP1569921A1 Ionic liquids comprising n(cf sb 3 /sb ) sb 2 /sb ] sp - /sp anions |
| 09/07/2005 | EP1569896A1 Tetrahydro-naphthalene derivatives |
| 09/07/2005 | EP1569893A2 Amino substituted hydroxyphenyl benzophenone derivatives |
| 09/07/2005 | EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 09/07/2005 | EP1192132B1 Serine protease inhibitors |
| 09/07/2005 | CN1665802A Bisarylsulfonamide compounds and their use in cancer therapy |
| 09/07/2005 | CN1665801A Anti tubercular drug: compositions and methods |
| 09/07/2005 | CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
| 09/07/2005 | CN1665475A Merocyanine derivatives for cosmetic use |
| 09/07/2005 | CN1217938C Bis-arylsulfones |
| 09/07/2005 | CN1217932C Antibacterial agents |
| 09/07/2005 | CN1217920C Compounds to treat Alzheimer disease |
| 09/07/2005 | CN1217918C Aminocyclohexyl ether compounds and uses thereof |
| 09/06/2005 | US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders |
| 09/06/2005 | US6939867 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents |
| 09/01/2005 | WO2005080363A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists |
| 09/01/2005 | WO2005080362A1 Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them |
| 09/01/2005 | WO2005080361A1 Histamine-3 receptor modulators |
| 09/01/2005 | WO2005080324A1 Sulfonamide derivatives for the treatment of diseases |
| 09/01/2005 | WO2005079863A1 Contrast medium for thrombus formation |
| 09/01/2005 | WO2005037772A3 Novel ligand activating receptors rars used for human medicine and cosmetics |
| 09/01/2005 | WO2005021523A8 Piperazine substituted compounds used as calcium channel blockers |
| 09/01/2005 | WO2004054991A8 Ionic liquids comprising [n(cf3)2]- anions |
| 09/01/2005 | US20050192430 For use as fluorescent labels with central nervous system drugs |
| 09/01/2005 | US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/01/2005 | US20050192289 Novel cinnamic amides |
| 09/01/2005 | US20050192286 Ligands of melanocortin receptors and compositions and methods related thereto |
| 09/01/2005 | US20050192283 Fused-aryl and heteroaryl derivatives and methods of their use |
| 09/01/2005 | US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation |
| 09/01/2005 | DE19964224B4 Pharmazeutische Mittel enthaltend Calcium-Komplex von Pharmaceutical preparations containing calcium complex of [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.N]-6,9-bis[(carboxy-.kappa.O)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-säure-.kappa.N6,.kappa.N9,.kappa.011]1-oxidato(6-)]-, tetrahydrogen (MS-325) und dessen Salze sowie Verfahren zur Herstellung der Mittel tetra hydrogen (MS-325) and salts thereof as well as methods for preparing the compositions |
| 09/01/2005 | CA2558064A1 Contrast medium for thrombus formation |
| 09/01/2005 | CA2556268A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists |
| 09/01/2005 | CA2555071A1 Histamine-3 receptor modulators |
| 09/01/2005 | CA2552433A1 Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them |
| 08/31/2005 | EP1568702A1 Palladium complexes with heterocyclic ligands |
| 08/31/2005 | EP1568686A1 n-alkylaminated secondary paraphenylendiamine, which is ortho- and/or meta-substituted, dying composition comprising this paraphenylendiamine, methods based on this composition and uses |
| 08/31/2005 | EP1568683A2 Secondary, N-alkylaminated para-phenylenediamines, compositions for dyeing keratinic fibres containing them, processes using this compositions and uses thereof |
| 08/31/2005 | EP1568355A1 N-alkylhydroxilated secondary paraphenylenediamine which is ortho- and/or meta substituted, composition for dying keratinous fibres comprising this paraphenylenediamine, methods based on this composition and uses. |
| 08/31/2005 | EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 08/31/2005 | EP1567510A1 Method for producing salts of tolperisone |
| 08/31/2005 | EP1567509A2 Biphenyl compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 08/31/2005 | EP1567498A2 Mandelic acid derivatives |
| 08/31/2005 | EP1567494A1 Methods for preparing phenylalkyne derivatives |
| 08/31/2005 | EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 08/31/2005 | CN1662517A Process for the production of N-(2, 6-dimethyl-phenyl)-2-piperazin-1-yl-acetamide |
| 08/31/2005 | CN1662516A N, N-disubstituted diazocycloalkanes |
| 08/31/2005 | CN1662515A Amorphous form of(-)-}2-}4-}(4-chlorophenyl)-phenyl methyl}-1-piperazinyl] ethoxy] acetic acid dihydrochloride (levocetririzine dihydrochloride) |
| 08/31/2005 | CN1662487A Amide linker peroxisome proliferator activated receptor modulators |
| 08/31/2005 | CN1660839A Chemical compounds |
| 08/31/2005 | CN1660826A Method for synthesizing (S)-isopropyl-(2-piperidine) phenyl-methylhistamine |
| 08/31/2005 | CN1660825A Method for preparing N-amino propyl morpholine |
| 08/30/2005 | US6936715 Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 08/30/2005 | US6936670 polymerizing an ethylenically unsaturated monomer with multifunctional alkoxyamine as living polymerization initiator |
| 08/30/2005 | US6936627 treating/preventing gastrointestinal disorders, inflammations and microbial infections; improving gastroprotective properties of H2 receptor antagonists; decreasing the recurrence of ulcers; facilitating ulcer healing |
| 08/30/2005 | US6936611 Serine protease inhibitors |
| 08/30/2005 | US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 08/30/2005 | US6936077 1,3-diamino-4-(aminomethyl)—benzene derivatives and colorants containing the said compounds |
| 08/30/2005 | CA2137747C Process for the continuous preparation of 2,2,6,6-tetramethylpiperidine |
| 08/25/2005 | WO2005077899A2 Amino-substituted tricyclic derivatives and methods of use |
| 08/25/2005 | WO2005077885A1 Ruthenium-catalyzed hydroamination of olefins |
| 08/25/2005 | WO2005077884A2 Hydroaminomethylation of olefins |
| 08/25/2005 | US20050187297 New compounds, methods for their preparation and use thereof |
| 08/25/2005 | US20050187272 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation |
| 08/25/2005 | US20050187251 Substituted N-heterocycle derivatives and methods of their use |
| 08/25/2005 | US20050187214 S-aminoalkylsulfonamides, e.g., 3-[4-(3-Chlorophenyl)piperazin-1-yl]propylsulfonyl-2,3-dihydro-1H-indole, used to lower IOP, improvi blood flow to the optic nerve head and the retina, provide neuroprotection, and treat retinal diseases, sleep disorders, depression, and other psychiatric disorders |